Correlation Between Estrella Immunopharma and Structure Therapeutics
Can any of the company-specific risk be diversified away by investing in both Estrella Immunopharma and Structure Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Estrella Immunopharma and Structure Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Estrella Immunopharma and Structure Therapeutics American, you can compare the effects of market volatilities on Estrella Immunopharma and Structure Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Estrella Immunopharma with a short position of Structure Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Estrella Immunopharma and Structure Therapeutics.
Diversification Opportunities for Estrella Immunopharma and Structure Therapeutics
-0.42 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Estrella and Structure is -0.42. Overlapping area represents the amount of risk that can be diversified away by holding Estrella Immunopharma and Structure Therapeutics America in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Structure Therapeutics and Estrella Immunopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Estrella Immunopharma are associated (or correlated) with Structure Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Structure Therapeutics has no effect on the direction of Estrella Immunopharma i.e., Estrella Immunopharma and Structure Therapeutics go up and down completely randomly.
Pair Corralation between Estrella Immunopharma and Structure Therapeutics
Assuming the 90 days horizon Estrella Immunopharma is expected to generate 0.14 times more return on investment than Structure Therapeutics. However, Estrella Immunopharma is 6.94 times less risky than Structure Therapeutics. It trades about -0.58 of its potential returns per unit of risk. Structure Therapeutics American is currently generating about -0.21 per unit of risk. If you would invest 9.20 in Estrella Immunopharma on September 1, 2024 and sell it today you would lose (0.10) from holding Estrella Immunopharma or give up 1.09% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 14.29% |
| Values | Daily Returns |
Estrella Immunopharma vs. Structure Therapeutics America
Performance |
| Timeline |
| Estrella Immunopharma |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
OK
| Structure Therapeutics |
Estrella Immunopharma and Structure Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Estrella Immunopharma and Structure Therapeutics
The main advantage of trading using opposite Estrella Immunopharma and Structure Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Estrella Immunopharma position performs unexpectedly, Structure Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Structure Therapeutics will offset losses from the drop in Structure Therapeutics' long position.| Estrella Immunopharma vs. Tff Pharmaceuticals | Estrella Immunopharma vs. Eliem Therapeutics | Estrella Immunopharma vs. Inhibrx | Estrella Immunopharma vs. Enliven Therapeutics |
| Structure Therapeutics vs. Day One Biopharmaceuticals | Structure Therapeutics vs. X4 Pharmaceuticals | Structure Therapeutics vs. Inozyme Pharma | Structure Therapeutics vs. Acumen Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Other Complementary Tools
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins |